Persistence Market Research Blog

Posts tagged ‘Mouth Ulcers Treatment Market’

Mouth Ulcers Treatment Market – Global Industry Analysis and Forecast to 2020

An ulcer is a break in the skin due to loss or degeneration of the surface tissue. Mouth ulcer refers to an ulcer that appears on the mucous membrane of the oral cavity. There are various types of mouth ulcers such as minor ulcers (diameter of around 2-8mm), major ulcers (bigger and deeper than minor ulcers), and herpetiform ulcers (a cluster of dozens of smaller sores). Some of the common causes for mouth ulcers are stress or tissue injury, excessive consumption of citric food such as lemons, oranges, apples, and others, impaired immune problems, and nutritional problems. Mouth ulcers can be prevented by avoiding tissue injury, keeping away from food that causes irritation in mouth, and maintaining oral hygiene. Apart from traditional methods, various drugs are used to treat mouth ulcers. Some of the major classes of drugs used to treat mouth ulcers are corticosteroids, analgesics, anesthetics, antihistamines, and antimicrobials. On the basis of type of product, the global market for mouth ulcers treatment can be classified as mouthwashes, gels, sprays, and lozenges. Based on indication, the market can be classified as aphthous stomatitis, oral lichen planus, and others.

Buy full report: http://www.persistencemarketresearch.com/market-research/mouth-ulcers-treatment-market.asp

North America dominates the global market for mouth ulcers treatment due to technical advancements in the field of dentistry and growing demand for pharmaceutical products in the region. Moreover, increased awareness about oral health and improved healthcare facilities are driving the market for mouth ulcers treatment in this region. Over the next few years, the market for mouth ulcers treatment in Asia is expected to experience a high growth rate, followed by Europe. China and India are expected to be the fastest growing markets in the Asia region. This is due to the large population base and increasing prevalence of mouth ulcers in these countries. Some of the key driving forces for the mouth ulcers treatment market in emerging economies are increasing awareness and improved healthcare facilities.

(more…)

Hepatitis Marker Testing Market – Global Industry Analysis and Forecast to 2020

The liver is an essential organ of the body which helps in digestion of food, removal of toxins from the blood, and storage of energy in the body. Inflammation of the liver usually due to viral infections, excessive alcohol consumption, and drugs can cause hepatitis. Hepatitis can be classified as hepatitis A, hepatitis B, hepatitis C, hepatitis D, and hepatitis E through laboratory testing. Acute infection may occur with no symptoms or limited symptoms such as jaundice, dark urine, nausea, extreme fatigue, vomiting, and abdominal pain. Hepatitis A is causes abdominal pain, jaundice, fever, nausea, and fatigue. The symptoms of hepatitis B include mild fever, diarrhea, muscle ache, skin rashes, and headache. Hepatitis C is a contagious liver disease that greatly damages the liver. Hepatitis B and C are most commonly cause of liver cancer, and cirrhosis. Hepatitis A and E are mainly caused by the ingestion of contaminated food. Hepatitis B, C, and D spread when a healthy person comes in contact with the bodily fluids of an infected person, receipt of contaminated blood or blood products, invasive medical procedure using contaminated equipment and by sexual contact. People suffering from hepatitis are tested with a range of markers depending on the symptoms exhibited, clinical history, and other tests. For instance, hepatitis B surface antigen is the vital marker for the screening and diagnosis of the hepatitis B virus. Similarly, anti-HAV IgM is a marker for the diagnosis of the hepatitis A virus.

Buy full report: http://www.persistencemarketresearch.com/market-research/hepatitis-marker-testing-market.asp

Chronic hepatitis is diagnosed through liver biopsy and blood tests. According to the World Health Organization (WHO), globally, 130 million to 150 million people suffer from chronic hepatitis C. Furthermore, globally, every year about 20 million and 1.4 million people are infected by hepatitis E and A respectively. WHO initiates various hepatitis awareness programs to reduce the transmission of agents that cause viral hepatitis, and, in turn, reduce the morbidity and mortality rates of the disease.

(more…)

Tag Cloud